SomnoMed Limited (SOM.AX)
AUD 0.43
(-18.87%)
AUD 0.43
(-18.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.32 Million AUD | -433.42% |
| 2023 | 698.39 Thousand AUD | 634.81% |
| 2022 | 820.82 Thousand AUD | -106.12% |
| 2021 | 3.57 Million AUD | 48.68% |
| 2020 | 4.3 Million AUD | -24.64% |
| 2019 | 3.11 Million AUD | -22.41% |
| 2018 | 3.66 Million AUD | 242.86% |
| 2017 | -2.51 Million AUD | -346.94% |
| 2016 | 1.51 Million AUD | 81.3% |
| 2015 | 573.33 Thousand AUD | -32.5% |
| 2014 | 849.36 Thousand AUD | 20.0% |
| 2013 | 707.78 Thousand AUD | -21.38% |
| 2012 | 900.28 Thousand AUD | 21.28% |
| 2011 | 742.33 Thousand AUD | 181.1% |
| 2010 | 174.69 Thousand AUD | 116.0% |
| 2009 | -1.65 Million AUD | 28.2% |
| 2008 | -2.25 Million AUD | 21.06% |
| 2007 | -2.91 Million AUD | 27.51% |
| 2006 | -4.01 Million AUD | -26.15% |
| 2005 | -3.6 Million AUD | -465.75% |
| 2004 | -562.73 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -343.3% |
| 2024 Q4 | -1.44 Million AUD | 0.0% |
| 2024 Q2 | -1.61 Million AUD | 0.0% |
| 2023 Q4 | 759.56 Thousand AUD | 0.0% |
| 2023 Q2 | 284.76 Thousand AUD | 0.0% |
| 2023 FY | - AUD | 634.81% |
| 2022 Q2 | -722.38 Thousand AUD | 0.0% |
| 2022 Q4 | 527.11 Thousand AUD | 0.0% |
| 2022 FY | - AUD | -106.12% |
| 2021 FY | - AUD | 48.68% |
| 2021 Q2 | 2.57 Million AUD | 0.0% |
| 2021 Q4 | 616.87 Thousand AUD | 0.0% |
| 2020 Q2 | 2.8 Million AUD | 0.0% |
| 2020 Q4 | -656.76 Thousand AUD | 0.0% |
| 2020 FY | - AUD | -24.64% |
| 2019 Q4 | 2.07 Million AUD | 0.0% |
| 2019 FY | - AUD | -22.41% |
| 2019 Q2 | 767.35 Thousand AUD | 0.0% |
| 2018 FY | - AUD | 242.86% |
| 2018 Q2 | 858.01 Thousand AUD | 0.0% |
| 2018 Q4 | 2.8 Million AUD | 0.0% |
| 2017 Q2 | 187.94 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -346.94% |
| 2017 Q4 | -2.75 Million AUD | 0.0% |
| 2016 Q2 | 737.65 Thousand AUD | 0.0% |
| 2016 Q4 | 301.79 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 81.3% |
| 2015 FY | - AUD | -32.5% |
| 2015 Q4 | 242.14 Thousand AUD | 0.0% |
| 2015 Q2 | 331.19 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 20.0% |
| 2014 Q4 | 212.68 Thousand AUD | 0.0% |
| 2014 Q2 | 636.67 Thousand AUD | 0.0% |
| 2013 Q2 | 615.1 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -21.38% |
| 2013 Q4 | 92.67 Thousand AUD | 0.0% |
| 2012 Q4 | 213.83 Thousand AUD | 0.0% |
| 2012 Q1 | 222.18 Thousand AUD | 0.0% |
| 2012 Q3 | 213.83 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 21.28% |
| 2012 Q2 | 213.83 Thousand AUD | -3.76% |
| 2011 FY | - AUD | 181.1% |
| 2011 Q1 | 67.71 Thousand AUD | 0.0% |
| 2011 Q2 | 222.18 Thousand AUD | 228.14% |
| 2011 Q3 | 222.18 Thousand AUD | 0.0% |
| 2011 Q4 | 222.18 Thousand AUD | 0.0% |
| 2010 Q4 | 67.71 Thousand AUD | 0.0% |
| 2010 Q1 | -371.02 Thousand AUD | 0.0% |
| 2010 Q2 | 67.71 Thousand AUD | 118.25% |
| 2010 Q3 | 67.71 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 116.0% |
| 2009 Q1 | -574.57 Thousand AUD | 0.0% |
| 2009 Q3 | -371.02 Thousand AUD | 0.0% |
| 2009 Q4 | -371.02 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 28.2% |
| 2009 Q2 | -371.02 Thousand AUD | 35.43% |
| 2008 Q4 | -574.57 Thousand AUD | 0.0% |
| 2008 Q3 | -574.57 Thousand AUD | 0.0% |
| 2008 Q2 | -574.57 Thousand AUD | 21.06% |
| 2008 Q1 | -727.84 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 21.06% |
| 2007 Q1 | -1 Million AUD | 0.0% |
| 2007 FY | - AUD | 27.51% |
| 2007 Q3 | -727.84 Thousand AUD | 0.0% |
| 2007 Q4 | -727.84 Thousand AUD | 0.0% |
| 2007 Q2 | -727.84 Thousand AUD | 27.51% |
| 2006 Q3 | -1 Million AUD | 0.0% |
| 2006 Q2 | -1 Million AUD | 37.73% |
| 2006 Q4 | -1 Million AUD | 0.0% |
| 2006 FY | - AUD | -26.15% |
| 2006 Q1 | -1.61 Million AUD | 0.0% |
| 2005 Q4 | -1.61 Million AUD | 0.0% |
| 2005 FY | - AUD | -465.75% |
| 2005 Q3 | -1.61 Million AUD | 0.0% |
| 2005 Q1 | -140.68 Thousand AUD | 0.0% |
| 2005 Q2 | -1.61 Million AUD | -1046.25% |
| 2004 Q2 | -140.68 Thousand AUD | 0.0% |
| 2004 Q4 | -140.68 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q3 | -140.68 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 93.544% |
| Adherium Limited | -11.56 Million AUD | 79.864% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 68.362% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 57.064% |
| Anteris Technologies Ltd | -66.9 Million AUD | 96.519% |
| Control Bionics Limited | -5.15 Million AUD | 54.856% |
| CardieX Limited | -6.71 Million AUD | 65.306% |
| Compumedics Limited | 2.78 Million AUD | 183.493% |
| Cochlear Limited | 579.5 Million AUD | 100.402% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 33.312% |
| Cyclopharm Limited | -3.03 Million AUD | 23.272% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -11.353% |
| Nova Eye Medical Limited | -5.97 Million AUD | 61.053% |
| HeraMED Limited | -3.97 Million AUD | 41.375% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 89.353% |
| ImpediMed Limited | -22.05 Million AUD | 89.44% |
| InhaleRx Limited | -1.41 Million AUD | -64.713% |
| LBT Innovations Limited | -4.04 Million AUD | 42.489% |
| Micro-X Limited | -14.35 Million AUD | 83.774% |
| Neurotech International Limited | -8.24 Million AUD | 71.754% |
| OncoSil Medical Limited | -11.97 Million AUD | 80.556% |
| PolyNovo Limited | 5.17 Million AUD | 145.041% |
| Respiri Limited | -7.04 Million AUD | 66.97% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 74.384% |
| Uscom Limited | -1.5 Million AUD | -54.283% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 52.645% |